Abstract
It is now widely accepted that cytolytic T cells recognize their antigens in the form of small peptides bound to major histocompatibility complex molecules at the surface of the target cells. We present here the hypothesis that, when these antigenic peptides are derived from the cellular genome, they are not degradation products of cellular proteins but can be generated directly by the autonomous transcription and translation of short subgenic regions that we propose to name “peptons”. We discuss some consequences of the notion that antigenic peptides can be produced in the absence of synthesis of messenger RNA and protein from the corresponding genes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allen P. M., Strydom, D., and Unanue, E. R.: Processing of lysozyme by macrophages: identification of the determinant recognized by two T cell hybridomas. Proc Natl Acad Sci USA 81: 2489–2493, 1984
Babbitt, B., Allen, P., Matsueda, G., Haber, E., and Unanue, E. R.: Binding of immunogenic peptides to la histocompatibility molecules. Nature 317: 359–361, 1985
Bevan, M. J.: Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier. Nature 256: 419–421, 1975
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., and Wiley, D. C.: The foreign antigen biding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512–518 1987
Boon, T.: Antigenic tumor cell variants obtained with mutagens. Adv Cancer Res 39: 121–151, 1983
Boon, T. and Kellermann, O.: Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc Natl Acad Sci USA 74: 272–275, 1977
Buus, S., Sette, A., Colon, S., Jenis, D., and Grey, H.: Isolation and charcterization of antigen-Ia complexes involved in T cell recognition. Cell 47: 1071–1077, 1986
Buus, S., Sette, A., Colon, S., Miles, C., and Grey, H. M.: The relaton between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 235: 1353–1358, 1987
de Duve, C. and Wattiaux, R.: Functions of lysosomes. Annu Rev Physiol 28: 435–492, 1966
De Plaen, E., Lurquin, C., Van Pel, A., Mariamé, B., Szikora, J.-P., Wölfel, T., Sibille, C., Chomez, P., and Boon, T.: Immunogenic (turn−) variants of mouse tumor P815: cloning of the gene of turn− antigen P91A and identification of the turn- mutation. Proc Natl Acad Sci USA 85: 2274–2278, 1988
Frost, P., Kerbel, R., Bauer, E., Tartamella-Biondo, R., and Cefalu, W.: Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Res 43: 125–132, 1983
Hämmerling, U. and Eggers, H. J.: Quantitative measurements of uptake of alloantibody on mouse lymphocytes. Eur J Biochem 17: 95–99, 1970
Hedrick, S., Cohen, D., Nielsen, E., and Davis, M.: Isolation of cDNA encoding T cell-specific membrane-associated proteins. Nature 308: 149–153, 1984
Kappler, J., Kuhn, R., Haskins, K., Hannum, C., Marrack, P., Pigeon, M., Mc Intire, B., Allison, J., and Trowbridge, I.: The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides. Cell 35: 295–302, 1983
Maryanski, J. L., Van Snick, J., Cerottini, J.-C., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. Eur J Immunol 12: 401–406, 1982
Maryanski, J. L., Pala, P., Corradin, G., Jordan, B. R., and Cerottini, J.-C.: H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature 324: 578–579, 1986
Shimonkevitz, R., Kappler, J., Marrack, P., and Grey, H. M.: Antigen recognition by H-2 restricted T cells. 1. Cell-free antigen processing. J Exp Med 158: 303–316, 1983
Shimonkevitz, R., Colon, S., Kappler, J., Marrack, P., and Grey, H. M.: Antigen recognition by H-2 restricted T cells. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol 133: 2067–2074, 1984
Townsend, A., Gotch, F., and Davey, J.: Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42: 457–467, 1985
Townsend, A., Bastin, J., and Brownlee, G.: Cytotoxic T lymphocytes recognize influenza hemagglutinin that lacks a signal sequence. Nature 324: 575–577, 1986a
Townsend, A., Rothbard, J., Gotch, F., Bahadur, G., Wraith, D., and McMichael,J.: The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959–968, 1986b
Uyttenhove, C., Van Snick, J., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. J Exp Med 152: 1175–1183, 1980
Wabuke-Bunoti, M., Taku, A., Fan, D., Kent, S., and Webster, R.: Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin. J Immunol 133: 2194–2201, 1984
Wölfel, T., Van Pel, A., De Plaen, E., Lurquin, C., Maryanski, J. L., and Boon, T.: Immunogenic (turn−) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a turn− antigen with cytolytic T cell stimulation assay. Immunogenetics 26: 178–187, 1987
Yanagi, Y., Yoshikai, Y., Leggett, K., Clark, S., Aleksander, I., and Mak, T.: A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chain. Nature 308: 145–149, 1984
Ziegler, H. K. and Unanue, E. R.: Decrease in macrophage antigen catabolism by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 79: 175–178, 1982
Zinkernagel, R. and Doherty, P.: Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248: 701–702, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boon, T., Van Pel, A. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis. Immunogenetics 29, 75–79 (1989). https://doi.org/10.1007/BF00395854
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00395854